Traded Mar 15 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Feb 20, 2026 · Filed Feb 24, 2026
Cognex's Global Sales and Products sold $213K of Cognex shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$212,979
Shares × reported transaction price
9 days after results of Feb 11, 2026, 75 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −7.4% | −1.2% | −6.2% |
| 30 days | −17.1% | −8.5% | −8.6% |
| 90 days | +19.0% | +8.3% | +10.7% |
| 180 days | +1.9% | +10.1% | −8.2% |
Past results only. Not a forecast.
Traded Mar 15 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Mar 15 · filed 1 day later
Routine share withholding; mechanical by default.
Traded Mar 15 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.